{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for "ORPHAN DRUG" in comments (approximate match)
Status:
Investigational
Source:
NCT03186677: Phase 1 Interventional Completed Hemophilia B
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03650348: Phase 1 Interventional Completed HER2-positive Breast Cancer
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03478488: Phase 3 Interventional Active, not recruiting Biliary Tract Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04256148: Phase 2 Interventional Withdrawn Warm Autoimmune Hemolytic Anemia
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03255070: Phase 1 Interventional Completed Breast Neoplasms
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03680508: Phase 2 Interventional Active, not recruiting Adult Primary Liver Cancer
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT04501939: Phase 2 Interventional Active, not recruiting Chronic Lymphocytic Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:briquilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03296696: Phase 1 Interventional Terminated Glioblastoma or Malignant Glioma
(2018)
Source URL:
Class:
PROTEIN
